Chemokines as targets for therapy (Q37849900)

24 August 2017

1 reference

title

Chemokines as targets for therapy (English)

1 reference

24 August 2017

Alexandre Garin

1

1 reference

PubMed ID

21376173

24 August 2017

Amanda E I Proudfoot

series ordinal

2

1 reference

PubMed ID

21376173

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Experimental Cell Research

24 August 2017

1 reference

24 August 2017

317

1 reference

24 August 2017

602-612

1 reference

24 August 2017

5

1 reference

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Frequency analysis of the CCR5delta32 mutation in patients with brucellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Blood monocytes consist of two principal subsets with distinct migratory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A critical role for eosinophils in allergic airways remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Chemokine receptors in airway disease: which receptors to target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CC chemokine receptor 5 and renal-transplant survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Proteolytic activation of alternative CCR1 ligands in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCR1 antagonists: what have we learned from clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Chemokines and other mediators as therapeutic targets in psoriasis vulgaris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The chemokine receptor D6 limits the inflammatory response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Increased inflammation in mice deficient for the chemokine decoy receptor D6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ + gut intraepithelial lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Endocytosis and recycling of the HIV coreceptor CCR5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Combined chemokine and cytokine gene transfer enhances antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CXCR7 protein is not expressed on human or mouse leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCL2 blockade augments cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Involvement of chemokine receptors in breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The role of chemokines in melanoma tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

Computer modeling of promoter organization as a tool to study transcriptional coregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.12.021

10.1016/J.YEXCR.2010.12.021

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21376173